Instructions for completing the Clinical Trial Site Information Form

Instructions for completing the Clinical Trial Site Information Form The Clinical Trial Site Information (CTSI) form is required to be submitted by clinical trial sponsors prior to initiating a protocol or implementing subsequent amendment(s) at the clinical trial site for trials that are subject to Division 5 of Part C of the Food and Drug Regulations or the Clinical Trials for Medical Devices and Drugs Relating to COVID-19 Regulations. 2022-06-07 Health Canada open-ouvert@tbs-sct.gc.ca Health and Safetyclinical-trial site-information formCTSI forminstructions for completingclinical-trial sponsors Instructions for completing the Clinical Trial Site Information FormHTML https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/forms/instructions-clinical-trial-information-form.html Instructions for completing the Clinical Trial Site Information FormHTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/formulaires/instructions-formulaire-information-essai-clinique.html

The Clinical Trial Site Information (CTSI) form is required to be submitted by clinical trial sponsors prior to initiating a protocol or implementing subsequent amendment(s) at the clinical trial site for trials that are subject to Division 5 of Part C of the Food and Drug Regulations or the Clinical Trials for Medical Devices and Drugs Relating to COVID-19 Regulations.

Data and Resources

Similar records